Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris

A man with pityriasis rubra pilaris (PRP) showed no improvement in skin symptoms despite treatment with several drugs. The patient was diagnosed as having type 1 PRP. Combination therapy with cyclosporine and guselkumab improved his skin condition. Here, we propose a novel therapeutic strategy for i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Mai, Kondo, Makoto, Habe, Koji, Hayashi, Akinobu, Yamanaka, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540577/
https://www.ncbi.nlm.nih.gov/pubmed/36245447
http://dx.doi.org/10.1002/ccr3.6413
_version_ 1784803738166231040
author Nishimura, Mai
Kondo, Makoto
Habe, Koji
Hayashi, Akinobu
Yamanaka, Keiichi
author_facet Nishimura, Mai
Kondo, Makoto
Habe, Koji
Hayashi, Akinobu
Yamanaka, Keiichi
author_sort Nishimura, Mai
collection PubMed
description A man with pityriasis rubra pilaris (PRP) showed no improvement in skin symptoms despite treatment with several drugs. The patient was diagnosed as having type 1 PRP. Combination therapy with cyclosporine and guselkumab improved his skin condition. Here, we propose a novel therapeutic strategy for intractable PRP.
format Online
Article
Text
id pubmed-9540577
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95405772022-10-14 Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris Nishimura, Mai Kondo, Makoto Habe, Koji Hayashi, Akinobu Yamanaka, Keiichi Clin Case Rep Case Report A man with pityriasis rubra pilaris (PRP) showed no improvement in skin symptoms despite treatment with several drugs. The patient was diagnosed as having type 1 PRP. Combination therapy with cyclosporine and guselkumab improved his skin condition. Here, we propose a novel therapeutic strategy for intractable PRP. John Wiley and Sons Inc. 2022-10-07 /pmc/articles/PMC9540577/ /pubmed/36245447 http://dx.doi.org/10.1002/ccr3.6413 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Nishimura, Mai
Kondo, Makoto
Habe, Koji
Hayashi, Akinobu
Yamanaka, Keiichi
Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris
title Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris
title_full Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris
title_fullStr Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris
title_full_unstemmed Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris
title_short Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris
title_sort successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540577/
https://www.ncbi.nlm.nih.gov/pubmed/36245447
http://dx.doi.org/10.1002/ccr3.6413
work_keys_str_mv AT nishimuramai successfultreatmentwithcyclosporineandguselkumabforpityriasisrubrapilaris
AT kondomakoto successfultreatmentwithcyclosporineandguselkumabforpityriasisrubrapilaris
AT habekoji successfultreatmentwithcyclosporineandguselkumabforpityriasisrubrapilaris
AT hayashiakinobu successfultreatmentwithcyclosporineandguselkumabforpityriasisrubrapilaris
AT yamanakakeiichi successfultreatmentwithcyclosporineandguselkumabforpityriasisrubrapilaris

Ejemplares similares